Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2003-11-21
2008-09-09
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S145100, C530S388100
Reexamination Certificate
active
07422743
ABSTRACT:
Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
REFERENCES:
patent: 5888774 (1999-03-01), Decluve
patent: 6495667 (2002-12-01), Bazan
patent: 2003/0009018 (2003-01-01), Maeda et al.
patent: 2003/0082734 (2003-05-01), Dowling et al.
patent: 2004/0156849 (2004-08-01), Gurney
patent: 2004/0219150 (2004-11-01), Cua et al.
patent: 2005/0106673 (2005-05-01), Dowling et al.
patent: WO 00/73451 (2000-12-01), None
patent: WO 01/18051 (2001-03-01), None
patent: WO 01/85790 (2001-11-01), None
patent: WO 02/29060 (2002-04-01), None
Pettit et al. The development of site-specific drug -delivery systems for protein and peptide biopharmaceuticals(1998), Trens in Biotech 16; 343-349.
Opalinska et al. Nucleic-Acid Therapeutics: Basic Principles and Recent Applications (2002), Nature Reviews Drug Discovery, vol. 1, p. 503-514.
S. Aggarwal, et al.,J. Biol. Chem. 278(3):1910-1914, Jan. 17, 2003. “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by production of interleukin-17”.
Kim E. Barrett,Baillieres Clin. Gastroenterol., 10(1): Mar. 1-15, 1996. “Cytokines: sources, receptors and signalling”.
J. Fernando Bazan, et al.,Nature, 379:591, Feb. 15, 1996. “A newly defined interleukin-1?”.
Christoph Becker, et al.,J. Clin. Invest. 112:693-706, Sep. 2003. “Constitutive p40 promoter activation and IL-23 production in the terminial ileum mediated by dendritic cells.”
J. Briscoe, et al.,Philos. Trans. R. Soc. Lond. B Biol. Sci. 351(1336):167-71, Feb. 29, 1996. “JAKs, STATs and signal transduction in response to the interferons and other cytokines”.
Irwin M. Chaiken and William V. Williams,Trends Biotechnol., 14(10):369-75, Oct. 1996. “Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design”.
Andrea M. Cooper, et al.,J. Immunol., 168:1322-1327, 2002. “Mice lacking bioactive IL-12 can generated protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present”.
Daniel J. Cua, et al.,Nature, 421:744-748, Feb. 13, 2003. “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain”.
Thomas J. Gonda and Richard J. D'Andrea,Blood, 89(2):355-369, Jan. 15, 1997. “Activating mutations in cytokine receptors: implications for receptor function and role in disease”.
Kyle I. Happel, et al.,J. Immunol., 170:4432-4436, 2003. “Cutting edge:roles of toll-like receptor 4 and IL-23 in IL-17 expression in response toKlebsiella pneumoniaeinfection”.
Peter C. Heinrich, et al.,Biochem. J., 334 (Pt 2):297-314, Sep. 1, 1998. “Interleukin 6-type cytokine signalling through the gp130/Jak/STAT pathway”.
Jeffrey M. Herz, et al.,J. Recept. Signal Transduct. Res., 17(5):671-776, Sep. 1997. “Molecular approaches to receptors as targets for drug discovery”.
M. Hibi, et al.,GenBank, Accession No. M57230, Jan. 6, 1995. “Definition: Human membrane glycoprotein gp130 mRNA, complete cds.”
Christoph Holscher, et al.,J. Immunol., 167:6957-6966, 2001. “A protective and agonistic function of IL-12p40 in mycobacterial infection”.
James N. Ihle, et al.Stem Cells, 15 (Suppl 1):105-11, 1997. “Jaks and Stats in cytokine signaling”.
David E. Levy,Cytokine Growth Factor Rev., 8(1):81-90, Mar. 1997. “The house that JAK/STAT built”.
Tamara Krajina, et al.,Eur. J. Immunol., 33:1073-1083, 2003. “Colonic lamina propria dendritic cells in mice with Cd4+T cell-induced colitis”.
S. Lok, et al., Database EMBL Online!, Accession No. AF178684, Sep. 10, 1999. “Definition:Homo sapiensclass I cytokine receptor (zcytor5) mRNA, complete cds”.
Christi Parham, et al.,J. Immunol. 168:5699-5708, 2002. “A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rb1 and a novel cytokine receptor subunit, IL-23R”.
Neela Patel, et al.,J. Biol. Chem., 271(48):30386-30391, Nov. 29, 1996. “Functional replacement of cytokine receptor extracellular domains by leucine zippers”.
David H. Presky, et al.,Proc. Natl. Acad. Sci. USA, 93:14002-14007, Nov. 1996. “A functional interleukin 12 receptor complex is composed of two b-type cytokine receptor subunits”.
D.H. Presky, et al.,GenBank, Accession No. U64198, Nov. 28, 2000. “Definition: Human IL-12 receptor beta2 mRNA, complete cds.”
Olli Silvennoinen, et al.,APMIS, 105(7):497-509, Jul. 1997. “Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors”.
Holm H. Uhlig and Fiona Powrie,J. Clin. Invest., 112(5)648-651, Sep. 2003. “Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune reponses.”
M. T. Wiekowski, et al.,J. Immunol., 166:7563-7570 (2001). “Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death”.
R.H. Waterston,Database EMBL Online!, Accession No. AC26054, Mar. 20, 2000. “Definition:Homo sapienschromosome 1 clone RP11-131015, working draft sequence, 26 unordered pieces.”
Linda A. Winston and Tony Hunter,Current Biology, 6(6):668-671, Jun. 1, 1996. “Intracellular signalling: Putting JAKs on the kinase MAP”.
Mahairas, et al. (Aug. 1999)Proc. Natl. Acad. Sci. USA96:9739-9744 “Sequence-tagged connectors: A sequence approach to mapping and scanning the human genome”.
Ngo, et al. (1994)The Protein Folding Problem and Tertiary Structure Predictionpp. 491-495 “Computational complexity, protein structure prediction, and the Levinthal Paradox”.
Phillips (2001)J. Pharmacy and Pharmacology53:1169-1174 “The challenge of gene therapy and DNA delivery”.
Scott, et al. (Apr. 1999)Nature Genetics21:440-443 “The Pendred syndrome gene encodes a chloride-iodide transport protein”.
Waldvogel, Database EMBL Online!, Accession No. AJ308426.
Wang et al. (Nov. 1992)Genomics14(3):666-672,Abstract. “Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130”.
Wells (Sep. 18, 1990)Biochemistry29(37):8509-8517 “Additivity of Mutational Effects in Proteins”.
Chirica Madaline
Kastelein Robert A.
Moore Kevin W.
Parham Christi L.
Bellomy Gregory R.
Brody Tom
Ching Edwin P.
Saoud Christine J
Schering Corporation
LandOfFree
Mammalian receptor protein DCRS5;methods of treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian receptor protein DCRS5;methods of treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian receptor protein DCRS5;methods of treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3987408